These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

1228 related items for PubMed ID: 16381336

  • 21.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 22. Demonstration of Trichomonas vaginalis in tracheal aspirates in infants with early respiratory failure.
    Temesvári P, Kerekes A, Tege A, Szarka K.
    J Matern Fetal Neonatal Med; 2002 May; 11(5):347-9. PubMed ID: 12389679
    [Abstract] [Full Text] [Related]

  • 23. 'Shelf life' of Trichomonas vaginalis.
    Kingston MA, Bansal D, Carlin EM.
    Int J STD AIDS; 2003 Jan; 14(1):28-9. PubMed ID: 12590789
    [Abstract] [Full Text] [Related]

  • 24. Management of metronidazole-resistant Trichomonas vaginalis--a new approach.
    Mammen-Tobin A, Wilson JD.
    Int J STD AIDS; 2005 Jul; 16(7):488-90. PubMed ID: 16004628
    [Abstract] [Full Text] [Related]

  • 25. Treatment of metronidazole-resistant Trichomonas vaginalis.
    Goldman LM, Upcroft JA, Workowski K, Rapkin A.
    Sex Health; 2009 Dec; 6(4):345-7. PubMed ID: 19917205
    [Abstract] [Full Text] [Related]

  • 26. Neonatal respiratory tract involvement by Trichomonas vaginalis: a case report and review of the literature.
    Carter JE, Whithaus KC.
    Am J Trop Med Hyg; 2008 Jan; 78(1):17-9. PubMed ID: 18187779
    [Abstract] [Full Text] [Related]

  • 27.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 28. Trichomoniasis among women with vaginal discharge in Benghazi city, Libya.
    Kassem HH, Majoud OA.
    J Egypt Soc Parasitol; 2006 Dec; 36(3):1007-16. PubMed ID: 17153709
    [Abstract] [Full Text] [Related]

  • 29.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 30.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 31. Alternative drugs against Trichomonas vaginalis.
    Mahdi NK, Gany ZH, Sharief M.
    East Mediterr Health J; 2006 Sep; 12(5):679-84. PubMed ID: 17333809
    [Abstract] [Full Text] [Related]

  • 32. Anti-Trichomonas vaginalis activity of ursolic acid derivative: a promising alternative.
    Bitencourt FG, de Brum Vieira P, Meirelles LC, Rigo GV, da Silva EF, Gnoatto SCB, Tasca T.
    Parasitol Res; 2018 May; 117(5):1573-1580. PubMed ID: 29572567
    [Abstract] [Full Text] [Related]

  • 33.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 34.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 35. Trichomoniasis: evaluation to execution.
    Harp DF, Chowdhury I.
    Eur J Obstet Gynecol Reprod Biol; 2011 Jul; 157(1):3-9. PubMed ID: 21440359
    [Abstract] [Full Text] [Related]

  • 36. A randomized treatment trial: single versus 7-day dose of metronidazole for the treatment of Trichomonas vaginalis among HIV-infected women.
    Kissinger P, Mena L, Levison J, Clark RA, Gatski M, Henderson H, Schmidt N, Rosenthal SL, Myers L, Martin DH.
    J Acquir Immune Defic Syndr; 2010 Dec 15; 55(5):565-71. PubMed ID: 21423852
    [Abstract] [Full Text] [Related]

  • 37.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 38.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 39.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 40. Persistent and recurrent Trichomonas vaginalis infections: epidemiology, treatment and management considerations.
    Seña AC, Bachmann LH, Hobbs MM.
    Expert Rev Anti Infect Ther; 2014 Jun 15; 12(6):673-85. PubMed ID: 24555561
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 62.